Spondyloarthritis

FDA Receives Upadacitinib Application for Ankylosing Spondylitis & Approves Tramadol Hydrochloride Oral Solution

September 30, 2020 • By Michele B. Kaufman, PharmD, BCGP

Study Finds Health & Financial Benefits in AxSpA Treat-To-Target Strategy

September 11, 2020 • By Thomas R. Collins

Non-Radiographic Axial Spondyloarthritis Recognized with ICD-10 Code

August 21, 2020 • By Larry Beresford

Interleukin 17 Inhibitors Promising in Ankylosing Spondylitis Patients

July 10, 2020 • By Michele B. Kaufman, PharmD, BCGP

Clinical Pearls: What We Know About Nonradiographic Axial Spondyloarthritis

June 16, 2020 • By Jason Liebowitz, MD

Axial Spondyloarthritis & Exercise: Should axSpA Patients Exercise?

March 23, 2020 • By Mike Fillon

Key Studies Highlighted: 2 Industry Veterans Discuss Their Favorite Annual Meeting Abstracts

March 19, 2020 • By Mike Fillon

From Chronic Low Back Pain to Axial Spondyloarthritis

February 13, 2020 • By Mike Fillon

Increased Risk of Inflammatory Arthritis with Hidradenitis Suppurativa

January 27, 2020 • By Will Boggs, MD

Ankylosing Spondylitis & Uveitis: An Ophthalmologist’s Perspective

December 18, 2019 • By Jason Liebowitz, MD